Physiology Flashcards

1
Q

Components of BBB

A

Endothelium with tight junctions and no fenestrations

Pericytes

Astrocyte processes that surround endothelium and have K+ and aquaporin pores for solute transfer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Requirements for drugs that can cross BBB

A

Low degree of ionisation at physiological pH

Low degree of plasma protein binding

High degree of lipid solubility in unionised state.

Inflam increases BBB permeability

Drugs enter the CSF predominantly via passive diffusion down a concentration gradient, the main determinant is high lipid solubility.

Drugs usually have a longer half life in the CSF than serum which may be beneficial as the BBB is repaired.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is neuron electrochemical gradient/how is it generated

A

Na/K ATPase uses ATP to export 3Na and import 2K → [Na] greater outside the cell, [K] greater inside the cell and establishment of an electrical gradient (more negative inside the cell).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Impulse generation in neuron

A
  1. Neuron depolarized to the threshold of -55mV through summation of EPSP at axon hillock → opening of voltage gated Na channels
    (inhibited by anti-seizure medications)
  2. Na diffuses INTO cell towards concentration and electrochemical equilibration
  3. Inactivation gate closes the channel just before this equilibrium potential is reached (35mV), preventing further Na influx for a brief period
    (inhibited by excitatory toxins like pyrethrins)
  4. Na/K ATPase starts response to depolarisation → rapid influx of K until its equilibrium threshold is reached at -90mV.
    (inhibited in low energy states like hypoxia and hypoglycaemia –> hyperexcitability)
  5. After-hyperpolarization of the membrane occurs until it reaches RMP of -65mV by passive diffusion of K out of cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What affects transmission speed of AP

A

axon internal diameter and myelination

Diameter - ↑ results in ↓ in resistance to flow of ions, However this also ↑ the difference in charge between the inside and outside of cell (capacitance) → resistance to flow

Myelination - ↓ ability of membrane in that area to store a charge (↓ capacitance) without affecting resistance. Prevents exchange of ions so AP jumps between nodes of Ranvier

(demyelination thus results in increased capacitance and slowing of conduction velocity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What occurs when AP reaches nerve terminal

A

Depolarisation of nerve terminal → activation of voltage-gated Ca channels → influx of Ca → activation of synaptic proteins (syntaxin, SNAP-25, synaptotagmin) that dock vesicles to presynaptic membrane for it to fuse → release contents into the synapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

4 classes of NT and whether they are excitatory or inhibitory

A

Class 1; Ach; mostly excitatory, except vagus
Synthesised from acetyl coA, plus choline, with choline acetyltransferase.
Preganglionic in all Autonomic (PSNS & SNS) nerves
Postganglionic neurons bear nicotinic Ach receptors.
Postganglionic in PSNS (muscarinic)

Class 2; Amines
NorAdr – Brainstem, hypothalamus – excitatory (Postganglionic SNS – may be inhibitory or excitation)
DOPA – Inhibitory
Serotonin – Inhibitory

Class 3; Amino Acids
Glycine – Inhibitory, mostly SC
GABA (gamma aminobutyric acid) – Inhibitory (SC, Cerebellum)
Glutamate – Excitatory

Class 4 (atypical); NO
Produces more long term metabolic changes (memory)
Atypical neurotransmitters are actually produced by the post-synaptic neuron following normal synaptic transmission they diffuse back across the synapse to affect the function of the presynaptic neuron (endocannabinoids and nitric oxide)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Main ionotropic receptors

A

Nicotinic -> Na channel opening
(blocked by MG autoantibodies)

GABA –> opens Cl channels
(antiseizure meds block)

AMPA and NMDA Glutamate receptors –> permeable to MG and Ca respectively
(overactivation results in excitotoxicity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is muscle contraction caused

A

ACh is released from motor neurons and binds nic ACh R on the muscle cell, these are ligand-gated Na channels which depolarise the muscle fibre.
This depolarisation is sufficient to activate voltage-gated Na channels
–> transmitted to the interior of the muscle fibre along the T tubules.
–> Opens sarcomeric voltage gated Ca channels
–> Ca release opens Ca-activated Ca channels

Ca binds troponin so it dissociates from myosin and allows excitation contraction coupling of myosin and actin

–> Ca actively pumped back into sarcomere at end of AP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Neostigmine and Pyridostigmine MOA and AEs

A

Both are Acetylcholinesterase inhibitors
–> longer duration of Ach in NMJ

–> increased stimulus for muscle AP generation
Used in MG where the number of nic ACh receptors are reduced

AEs: cholinergic effects and can be systemic, often dose depending
Pyridostigmine is less potent and slower in onset so is less likely to cause a cholinergic crisis
Nausea, diarrhoea, salivation, lacrimation, Bradycardia, Miosis,m bronchospasm and respiratory arrest, cramps and weakness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Where/How is CSF formed and how does it differ from plasma.

A

Ependymal cells in the chorid plexus (an invagination of the ependyma into the ventricular cavities.

Capillaries here are fenestrated unlike the rest of the BBB so solutes and water can move in/out.

The CSF has similar Na levels to plasma but more Mg and Cl and less K and HCO3. Osmolality is the same as plasma

This is mediated by apical Na/K ATPase on the apical surface of ependymal cells removing K from CSF. Because 3Na+ enter and 2K+ leave the CSF this generates a gradient to draw water and Cl into the CSF.

Intracellular carbonic anhydrase using CO2 produced by cells in the brain to generate H+ that is then actively exported into the blood in exchange for Na into the ependymal cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Normal CSF circulation and drainage

A

In normal conditions produced at a rate similar to drainage.

Choroid plexus at the intraventricular foramen produces CSF and flows into lateral ventricles then into third ventricle (under pituitary) through cerebral aqueduct into fourth ventricle (under cerebellum) where it can either flow on through the ventral canal of the spinal cord or enter the median/lateral apertures and enter the subarachnoid space where it is absorbed by arachnoid microvilli in the dural venous sinuses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CSF functions

A

Removes waste from brain, brings in some vitamins/micronutrients (not brought in by BBB capillaries)

Acid base balance

Regulation of intracranial pressure

Maintains a chemical environment for neuronal signalling

Physical absorption of shock preventing brain injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Indications of hyperexcitability on EMG and what it may mean

A

EMG measures the ECF electrical activity (as a surrogate for muscle) at insertion, contraction and in response to nerve stimulation

Normal muscle has short insertional activity due to mechanical damage to the myofibril) and low amplitude miniature end plate potentials representing tonic low grade nerve stimulation that do not depolarise the entire myofibre

In disease the muscle becomes hyperexcitable resulting in:
Increased insertional activity
Fibrillation potentials and positive sharp waves (spontaneous firing of hypersensitive myofibres); Complex repetitive discharges (repetitive uniform waves).

These are a result of abnormalities of the muscle caused by denervation which alters metabolism and makes the myofibre more sensitive to ACh. these changes take about 4-5d to ocurr after denervation (due to hypoTH, nerve tumours, polyrad, protozoal neuropathy)

Another differential though is myositis can also cause increased activity or muscular dystrophy can cause complex repetitive discharges

This differentiates denervation from atrophy of disuse where there may be fibrosis and reduced excitability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Motor nerve conduction studies and causes of reduced amplitude, conduction velocity and prox vs distal CMAP.

A

Measures compound muscle action potentials CMAP after stimulation of motor nerve.

Reduced CMAP amplitude indicates loss of innervation (axonopathy) sucha s with polyradiculoneuritis, Myaesthenia gravis or severe myopathy.
Can also see with Botox or tick paralysis induced reduction in NM transmission

Reduced conduction velocity without loss of amplitude is seen with demyelination due to diabetic neuropathy, hypoTH

Prox vs distal CMAP difference = conduction block
Occurs when there is segmental demyelination
Also commonly seen in diabetic neuropathy or demyelinating polyneuropathy

disorders of muscle wont affect these

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the pyramidal neurons

A

These are UMN from the CNS that can be inhibitory or excitatory and modulate involuntary reflexes.

17
Q

Brain blood supply (species differences) and its purpose

A

Cerebral arterial circle ensures constant pressure in the end arteries, allowing for collateral perfusion of the parenchyma in the event of arterial occlusion

Dogs get blood from basilar a and internal carotids similar to people. cats have craniocadal blood flow in the basilar artery (opposite) and most of the brain blood supply comes from EXTERNAL carotid arteries.

18
Q

What factors determine cerebral blood flow and how do MAP, CO2 and O2 affect them

A

CF = cerebral perfusion pressure / cerebral vascular resistance

Maintained at constant if MAP is 50-150mmHg in health.

MAP increase causes vasoconstriction and decrease BP –> dilation.

CO2 increase causes vasodilation and decrease constriction (O2 is the opposite)

19
Q

Mechanisms that pathogen can enter brain and what occurs after entry

A

Paracellular pathways

Transcellular transport

Intracellularly within leukocytes

Or trauma causing direct penetration

Once a pathogen enters the BBB there is stimulation of the host inflammatory response.

–> activation of host inflammatory response:
- IL1,6,10 activate inflammatory pathways, chemoattractants (TNFa, IL 8 ) allow entry of cells
- MMP breakdown ECM –> leukocyte migration

–> ongoing inflammation causes breakdown of BBB

20
Q

Difference b/w cardiac myocytes and skeletal muscle

A

Have sarcoplasmic reticulum and myofibrils but are shorter and coupled by intercalated discs to allow continuity of the cytoplasm b/w adjacent cells –> spread of depolarisation

Higher resting membrane potential –> reach threshold faster than skeletal muscle cells

More reliant on extracellular Ca supplies than Sk musc (no sarcoplasmic reticulum stores)

The influx of Ca during phase 2 (voltage gated Ca channels) electrically balances with the efflux of K+ and prolongs the contraction –> prevents further contraction

Which is why in hypocalcaemia the cardiac myocytes are hyperexcitable and why Ca can help stabilise membrane potentials in hyperkalaemia

21
Q

Differences b/w smooth and skeletal muscle

A

Smooth muscle has no T tubules, relies on transmembrane diffusion of Ca from ECF

Do not have uniform structure so contraction result sin ‘wrinkling’ (actin filaments anchored to dense bodies)

Have gap junctions b/w cells and can operate as a functional syncytium with cell to cell transmission of contraction potential

Autonomic innervation - ACh and Norad and receive input from >1 neuron

Can also contract in response to self induced generation of electrical activity, hormone actions or stress

ca binds to calmodulin (not troponin) and activates myosin kinase which generates myosin changes that result in contraction

22
Q

Different contraction AP types in smooth muscle

A

Spike potentials - same as sk musc

Plateaus - due to slower closing of Ca channels

Slow wave - self excitatory, rhythmic. Changes membrane potential to make contraction more or less likely (does not result in contraction on its own)

23
Q

Normal Pain pathway components

A

TRANSDUCTION
Initial stimulus (mechanical, thermal or chemical)
–> activates peripheral sensory neurons

(d fibre for fast mechanical or thermal; C fibre slower for chemical)

TRANSMISSION
Signal ascends sensory neuron to the dorsal root ganglion where the nerve cell body is then enters the dorsal horn and synapses with interneuron (Sub P)
–> Interneuron (2nd order neuron) crosses to other side of spinal cord and ascends to the, via the spinothalamic tract brain somatosensory cortex (contralateral side to injury)

PERCEPTION
–> 2nd order neuron synapses on 3rd order neuron in thalamus which relays signal to somatosensory cortex
(contralateral

DESCENDING PATHWAY
- can be inhibiting or facilitating
- Inhibitory substances (GABA, 5HT, NorAd, CBD, Dopa)

MODULATION
- Descending inhibitory pathway from brain is constitutively active and releases 5HT and NorAd that inhibit the release of sub P from 1st order neuron
- Descending neuron also stimulates other interneurons in the dorsal horn –> release of endogenous opioids (enkephalin)
–>inhibits presynaptic neuron sub P release, and inhibits 2nd order neuron activation (stops signal to brain
- Also descending facilitatory signals that release Sub P, glutamate –> increasing sensitivity to stimuli

24
Q

Chemical stimuli that trigger pain response

A

PGs
LT
5HT
Histamine
K+
NGF

25
Q

What is chronic pain and what causes it

A

Pain persisting beyond the initial stimulus and healing time

Caused by neuroplasticity that results in sensitisation of the pain signalling system

–> recruitment of NMDA receptors on dorsal horn neurons
–> change in gene expression in nociceptor neurons

May be caused by change in neuroplasticity after injury or due to primary CNS dysfunction

26
Q

Clinical hallmarks of chronic (maladaptive pain)

A

Allodynia - pain from non-noxious stimuli in the general area

Hyperalgesia - increased sensitivity to noxious stimuli

27
Q

Pain behaviours

A

Movement/activity change
Altered sleeping position or posture at rest
Vocalisation
Gait change
Loss of body functions - anorexia, reluctance to defecate/urinate, poor grooming (or overgrooming)
Altered social behaviour (fear or aggression)

Physiological: tachycardia, tachypnoea, hypertension

28
Q

pathophysiological consequences of pain

A

Increases cardiac workload
Vagal inhibition
Ileus, nausea, vomiting
Oliguria
Thromboembolism
Fatigue

–> through stimulation of autonomic nervous system

29
Q

Types of pain

A

Nociceptive - due to noxious stimuli
Inflammatory - due to chemical stimuli, gradual via activation of immune system

Pathologic - maladaptive, amplified and sustained
–> hyperalgesia and allodynia

30
Q

JSAP 2022 review of OA pain mgmt options

A

NSAID - many studies of different products, no one agent has been superior to others for pain relief
AEs: GI most common and usually mild with more severe side effects in overdose. No known association with type of NSAID used.

Priprant (Grapriprant) - inhibitor of PGE2 receptor –> blocks sensitisation of sensory neurons by PGE2. Limited studies and none comparing to NSAIDs, long term efficacy studies lacking. GI side effects reported but generally mild.

PARACETAMOL
- COX inhibition peripherally, central serotinergic pathways
–> little to no evidence of efficacy in human meta-analysis
–> no published vet data in OA

Bedinvetmab (Frunevetmab for cats)
- mAb that binds to NGF which is normally involved in nociceptor sensitisation in both acute and chronic pain states (increases NT formation and induces inflammatory mediator release).
- Initial evidence shows efficacy for alleviating OA pain in dogs and cats, various AEs reported including worsening of renal dysfunction in cats(commonly dermatological, local reactions in cats)
- Long term safety/efficacy studies are lacking
- Concurrent use with NSAIDs in humans associated with rapid progression of OA. Has not been evaluated in vet med

Tramadol
- currently evidence as analgesic is unconvincing
- dogs have individual variability in the production of opioid active metabolite
- recent study in cats reported improved activity compared to placebo suggesting a beneficial effect in feline OA
- Limited evidence of benefit as sole agent but may be of benefit as adjunctive

GABAPENTIN
Inhibits VG Ca channels thereby reducing neuron excitability.
- Limited evidence for efficacy as pain relief

AMANTADINE
- NMDA R antagonist
- one study showing subjective improvement in OA pain when given in conjunction with meloxicam

CANNABIDIOL
- antinociceptive and antihyperalgesic effects
- mixed results in clinical trials and all of small size (30 or less)
- Very limited available evidence.

AMITRIPTYLINE
- no published studies in dogs.

Steroids
- Caution with long term use due to side effects

31
Q

What are structure modifying OA drugs

A

Delay, stabilise or repair OA lesions in affected joints rather than just alleviating symptoms

Pentosan Polysulfate
Glycosaminoglycans
Hyaluronic Acid
Doxycycline

Recent 4cyte study reported non-inferior to carprofen in randomised masked, placebo controlled study